Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Demorrow

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|April 12, 2021
Targeting Certain Interleukins as Novel Treatment Options for Liver FibrosisSu Yeon An, Anca D Petrescu, Sharon DeMorrow
Translational Gastrointestinal Cancer|September 25, 2012
Cholangiocarcinoma pathogenesis: Role of the tumor microenvironmentDinorah Leyva-Illades, Matthew McMillin, Matthew Quinn, et al.
World Journal of Gastrointestinal Pathophysiology|May 25, 2011
Aberrant DNA methylation profile in cholangiocarcinomaLi Huang, Gabriel Frampton, Li-Jian Liang, et al.
Experimental Cell Research|March 30, 2010
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signalingGabriel Frampton, Monique Coufal, Huang Li, et al.
World Journal of Gastrointestinal Pathophysiology|May 25, 2011
Biogenic amines serotonin and dopamine regulate cholangiocyte hyperplastic and neoplastic growthGabriel A Frampton, Huang Li, Jonathan Ramirez, et al.
Metabolic Brain Disease|December 10, 2024
CD47 signaling induces hepatic cell death and microglia activation during hepatic encephalopathyAshwin Jhawer, Gabriel Frampton, Shadikchhya Maya Bhattarai, et al.
Frontiers in Endocrinology|November 29, 2018
Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver DiseaseAnca D Petrescu, Jessica Kain, Victoria Liere, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2021
2021 ISHEN guidelines on animal models of hepatic encephalopathySharon DeMorrow, Cristina Cudalbu, Nathan Davies, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 12, 2010
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agentsGabriel A Frampton, Eric A Lazcano, Huang Li, et al.
Journal of Neuroinflammation|August 27, 2016
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in miceMatthew McMillin, Stephanie Grant, Gabriel Frampton, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|April 12, 2021
Targeting Certain Interleukins as Novel Treatment Options for Liver FibrosisSu Yeon An, Anca D Petrescu, Sharon DeMorrow
Translational Gastrointestinal Cancer|September 25, 2012
Cholangiocarcinoma pathogenesis: Role of the tumor microenvironmentDinorah Leyva-Illades, Matthew McMillin, Matthew Quinn, et al.
World Journal of Gastrointestinal Pathophysiology|May 25, 2011
Aberrant DNA methylation profile in cholangiocarcinomaLi Huang, Gabriel Frampton, Li-Jian Liang, et al.
Experimental Cell Research|March 30, 2010
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signalingGabriel Frampton, Monique Coufal, Huang Li, et al.
World Journal of Gastrointestinal Pathophysiology|May 25, 2011
Biogenic amines serotonin and dopamine regulate cholangiocyte hyperplastic and neoplastic growthGabriel A Frampton, Huang Li, Jonathan Ramirez, et al.
Metabolic Brain Disease|December 10, 2024
CD47 signaling induces hepatic cell death and microglia activation during hepatic encephalopathyAshwin Jhawer, Gabriel Frampton, Shadikchhya Maya Bhattarai, et al.
Frontiers in Endocrinology|November 29, 2018
Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver DiseaseAnca D Petrescu, Jessica Kain, Victoria Liere, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2021
2021 ISHEN guidelines on animal models of hepatic encephalopathySharon DeMorrow, Cristina Cudalbu, Nathan Davies, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 12, 2010
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agentsGabriel A Frampton, Eric A Lazcano, Huang Li, et al.
Journal of Neuroinflammation|August 27, 2016
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in miceMatthew McMillin, Stephanie Grant, Gabriel Frampton, et al.
Pageof 13